PB2 subunit | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,432 results for “PB2 subunit”

Trials

View all 810 →

Immunogenicity and Safety of Subunit Plague Vaccine

240 participants · First posted Nov 4, 2015

Safety of the Herpes Zoster Subunit Vaccine in Lupus

224 participants · First posted Sep 29, 2022

Preliminary Safety Assessment of a Quadrivalent Subunit Influenza Vaccine in China

3,105 participants · First posted Jul 17, 2026

Drugs

View all 387 →

PB2-39

KLH/SUBUNIT

Subunit Influenza Vaccine

Organizations

AB&B BIO-TECH-B

Neopenda, PBC

United States

Trek Therapeutics PBC

United States

News

View all 227 →

Zhongsheng Pharmaceutical Advances Pediatric Angladivir Granules to Phase III for Influenza A Treatment

CDSCO Panel Mandates Phase III Trial of Baloxavir Marboxil in Indian Population

China Approves First-in-Class Influenza Drug Onradivir Targeting Novel PB2 Protein

Page 1 of 144